4//SEC Filing
Russillo Thomas R 4
Accession 0001179110-10-017782
CIK 0000884629other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:11 PM ET
Size
11.9 KB
Accession
0001179110-10-017782
Insider Transaction Report
Form 4
Russillo Thomas R
EVP & Pres US Generics Div
Transactions
- Exercise/Conversion
Common Stock, par value $0.0033
2010-12-15$25.86/sh+11,598$299,924→ 74,968 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2010-12-15−48,402→ 0 totalExercise: $25.86From: 2009-12-31Exp: 2016-09-05→ Common Stock, par value $0.0033 (48,402 underlying) - Exercise/Conversion
Common Stock, par value $0.0033
2010-12-15$25.86/sh+48,402$1,251,676→ 123,370 total - Sale
Common Stock, par value $0.0033
2010-12-15$50.00/sh−60,000$3,000,000→ 63,370 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2010-12-15−11,598→ 0 totalExercise: $25.86From: 2009-12-31Exp: 2016-09-05→ Common Stock, par value $0.0033 (11,598 underlying)
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeother
Related Parties
1- filerCIK 0001374453
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:11 PM ET
- Size
- 11.9 KB